Snap Inc. Stock Underperforms Tuesday When Compared To Competitors

Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025 *W EXP 12/11/2025

Change company Symbol lookup

Select an option...

CYTHW Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025 *W EXP 12/11/2025

FR First Industrial Realty Trust Inc

PNI PIMCO New York Municipal Income Fund II

NIB iPath? Bloomberg Cocoa Subindex Total Return(SM) ETN

DG Dollar General Corp

SPCO Stephan Co

KEX Kirby Corp

GM General Motors Co

F Ford Motor Co

MSFT Microsoft Corp

Health Care : Biotechnology | Small Cap Value

Company profile

Cyclo Therapeutics, Inc. is a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company's lead drug candidate, Trappsol Cyclo (hydroxypropyl beta cyclodextrin) is for the treatment of Niemann-Pick Type C disease (NPC). NPC is a rare and fatal cholesterol metabolism disease that impacts the brain, lungs, liver, spleen, and other organs. It is also focusing on the use of cyclodextrins in the treatment of Alzheimer's disease. The Company's product lines include Trappsol and Aquaplex. It sells its chemical products directly to customers in the pharmaceutical, diagnostics, and industrial chemical industries, and to chemical supply distributors. The Company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.

Snap Inc. Stock Underperforms Tuesday When Compared To Competitors

5:20 pm ET May 31, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Snap Inc. (SNAP) shed 9.44% to $14.11 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.41% to 12,081.39 and Dow Jones Industrial Average falling 0.67% to 32,990.12. The stock's fall snapped a three-day winning streak. Snap Inc. closed $69.23 short of its 52-week high ($83.34), which the company reached on September 24th.

The stock underperformed when compared to some of its competitors Tuesday, as Apple Inc. (AAPL) fell 0.53% to $148.84, Twitter Inc. (TWTR) fell 1.42% to $39.60, and Meta Platforms Inc. (FB) fell 0.76% to $193.64. Trading volume (98.0 M) eclipsed its 50-day average volume of 38.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 31, 2022.

(END) Dow Jones Newswires

May 31, 2022 17:20 ET (21:20 GMT)